Effects of Atrial Fibrillation on the Human Ventricle

Standard

Effects of Atrial Fibrillation on the Human Ventricle. / Pabel, Steffen; Knierim, Maria; Stehle, Thea; Felix, Alebrand; Paulus, Michael; Sieme, Marcel; Herwig, Melissa; Barsch, Friedrich; Körtl, Thomas; Pöppl, Arnold; Wenner, Brisca; Ljubojevic-Holzer, Senka; Molina, Cristina; Dybkova, Nataliya; Camboni, Daniele; Fischer, Thomas H; Sedej, Simon; Scherr, Daniel; Schmid, Christof; Brochlausen, Christoph; Hasenfuß, Gerd; Maier, Lars S; Hamdani, Nazha; Streckfuss-Bömeke, Katrin; Sossalla, Samuel.

in: CIRC RES, Jahrgang 130, Nr. 7, 04.2022, S. 994-1010.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Pabel, S, Knierim, M, Stehle, T, Felix, A, Paulus, M, Sieme, M, Herwig, M, Barsch, F, Körtl, T, Pöppl, A, Wenner, B, Ljubojevic-Holzer, S, Molina, C, Dybkova, N, Camboni, D, Fischer, TH, Sedej, S, Scherr, D, Schmid, C, Brochlausen, C, Hasenfuß, G, Maier, LS, Hamdani, N, Streckfuss-Bömeke, K & Sossalla, S 2022, 'Effects of Atrial Fibrillation on the Human Ventricle', CIRC RES, Jg. 130, Nr. 7, S. 994-1010. https://doi.org/10.1161/CIRCRESAHA.121.319718

APA

Pabel, S., Knierim, M., Stehle, T., Felix, A., Paulus, M., Sieme, M., Herwig, M., Barsch, F., Körtl, T., Pöppl, A., Wenner, B., Ljubojevic-Holzer, S., Molina, C., Dybkova, N., Camboni, D., Fischer, T. H., Sedej, S., Scherr, D., Schmid, C., ... Sossalla, S. (2022). Effects of Atrial Fibrillation on the Human Ventricle. CIRC RES, 130(7), 994-1010. https://doi.org/10.1161/CIRCRESAHA.121.319718

Vancouver

Pabel S, Knierim M, Stehle T, Felix A, Paulus M, Sieme M et al. Effects of Atrial Fibrillation on the Human Ventricle. CIRC RES. 2022 Apr;130(7):994-1010. https://doi.org/10.1161/CIRCRESAHA.121.319718

Bibtex

@article{c9e764de1ce7461395ddca47757262ec,
title = "Effects of Atrial Fibrillation on the Human Ventricle",
abstract = "RATIONALE: Atrial fibrillation (AF) and heart failure often coexist, but their interaction is poorly understood. Clinical data indicate that the arrhythmic component of AF may contribute to left ventricular (LV) dysfunction.OBJECTIVE: This study investigates the effects and molecular mechanisms of AF on the human LV.METHODS AND RESULTS: Ventricular myocardium from patients with aortic stenosis and preserved LV function with sinus rhythm or rate-controlled AF was studied. LV myocardium from patients with sinus rhythm and patients with AF showed no differences in fibrosis. In functional studies, systolic Ca2+ transient amplitude of LV cardiomyocytes was reduced in patients with AF, while diastolic Ca2+ levels and Ca2+ transient kinetics were not statistically different. These results were confirmed in LV cardiomyocytes from nonfailing donors with sinus rhythm or AF. Moreover, normofrequent AF was simulated in vitro using arrhythmic or rhythmic pacing (both at 60 bpm). After 24 hours of AF-simulation, human LV cardiomyocytes from nonfailing donors showed an impaired Ca2+ transient amplitude. For a standardized investigation of AF-simulation, human iPSC-cardiomyocytes were tested. Seven days of AF-simulation caused reduced systolic Ca2+ transient amplitude and sarcoplasmic reticulum Ca2+ load likely because of an increased diastolic sarcoplasmic reticulum Ca2+ leak. Moreover, cytosolic Na+ concentration was elevated and action potential duration was prolonged after AF-simulation. We detected an increased late Na+ current as a potential trigger for the detrimentally altered Ca2+/Na+-interplay. Mechanistically, reactive oxygen species were higher in the LV of patients with AF. CaMKII (Ca2+/calmodulin-dependent protein kinase IIδc) was found to be more oxidized at Met281/282 in the LV of patients with AF leading to an increased CaMKII activity and consequent increased RyR2 phosphorylation. CaMKII inhibition and ROS scavenging ameliorated impaired systolic Ca2+ handling after AF-simulation.CONCLUSIONS: AF causes distinct functional and molecular remodeling of the human LV. This translational study provides the first mechanistic characterization and the potential negative impact of AF in the absence of tachycardia on the human ventricle.",
author = "Steffen Pabel and Maria Knierim and Thea Stehle and Alebrand Felix and Michael Paulus and Marcel Sieme and Melissa Herwig and Friedrich Barsch and Thomas K{\"o}rtl and Arnold P{\"o}ppl and Brisca Wenner and Senka Ljubojevic-Holzer and Cristina Molina and Nataliya Dybkova and Daniele Camboni and Fischer, {Thomas H} and Simon Sedej and Daniel Scherr and Christof Schmid and Christoph Brochlausen and Gerd Hasenfu{\ss} and Maier, {Lars S} and Nazha Hamdani and Katrin Streckfuss-B{\"o}meke and Samuel Sossalla",
year = "2022",
month = apr,
doi = "10.1161/CIRCRESAHA.121.319718",
language = "English",
volume = "130",
pages = "994--1010",
journal = "CIRC RES",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

RIS

TY - JOUR

T1 - Effects of Atrial Fibrillation on the Human Ventricle

AU - Pabel, Steffen

AU - Knierim, Maria

AU - Stehle, Thea

AU - Felix, Alebrand

AU - Paulus, Michael

AU - Sieme, Marcel

AU - Herwig, Melissa

AU - Barsch, Friedrich

AU - Körtl, Thomas

AU - Pöppl, Arnold

AU - Wenner, Brisca

AU - Ljubojevic-Holzer, Senka

AU - Molina, Cristina

AU - Dybkova, Nataliya

AU - Camboni, Daniele

AU - Fischer, Thomas H

AU - Sedej, Simon

AU - Scherr, Daniel

AU - Schmid, Christof

AU - Brochlausen, Christoph

AU - Hasenfuß, Gerd

AU - Maier, Lars S

AU - Hamdani, Nazha

AU - Streckfuss-Bömeke, Katrin

AU - Sossalla, Samuel

PY - 2022/4

Y1 - 2022/4

N2 - RATIONALE: Atrial fibrillation (AF) and heart failure often coexist, but their interaction is poorly understood. Clinical data indicate that the arrhythmic component of AF may contribute to left ventricular (LV) dysfunction.OBJECTIVE: This study investigates the effects and molecular mechanisms of AF on the human LV.METHODS AND RESULTS: Ventricular myocardium from patients with aortic stenosis and preserved LV function with sinus rhythm or rate-controlled AF was studied. LV myocardium from patients with sinus rhythm and patients with AF showed no differences in fibrosis. In functional studies, systolic Ca2+ transient amplitude of LV cardiomyocytes was reduced in patients with AF, while diastolic Ca2+ levels and Ca2+ transient kinetics were not statistically different. These results were confirmed in LV cardiomyocytes from nonfailing donors with sinus rhythm or AF. Moreover, normofrequent AF was simulated in vitro using arrhythmic or rhythmic pacing (both at 60 bpm). After 24 hours of AF-simulation, human LV cardiomyocytes from nonfailing donors showed an impaired Ca2+ transient amplitude. For a standardized investigation of AF-simulation, human iPSC-cardiomyocytes were tested. Seven days of AF-simulation caused reduced systolic Ca2+ transient amplitude and sarcoplasmic reticulum Ca2+ load likely because of an increased diastolic sarcoplasmic reticulum Ca2+ leak. Moreover, cytosolic Na+ concentration was elevated and action potential duration was prolonged after AF-simulation. We detected an increased late Na+ current as a potential trigger for the detrimentally altered Ca2+/Na+-interplay. Mechanistically, reactive oxygen species were higher in the LV of patients with AF. CaMKII (Ca2+/calmodulin-dependent protein kinase IIδc) was found to be more oxidized at Met281/282 in the LV of patients with AF leading to an increased CaMKII activity and consequent increased RyR2 phosphorylation. CaMKII inhibition and ROS scavenging ameliorated impaired systolic Ca2+ handling after AF-simulation.CONCLUSIONS: AF causes distinct functional and molecular remodeling of the human LV. This translational study provides the first mechanistic characterization and the potential negative impact of AF in the absence of tachycardia on the human ventricle.

AB - RATIONALE: Atrial fibrillation (AF) and heart failure often coexist, but their interaction is poorly understood. Clinical data indicate that the arrhythmic component of AF may contribute to left ventricular (LV) dysfunction.OBJECTIVE: This study investigates the effects and molecular mechanisms of AF on the human LV.METHODS AND RESULTS: Ventricular myocardium from patients with aortic stenosis and preserved LV function with sinus rhythm or rate-controlled AF was studied. LV myocardium from patients with sinus rhythm and patients with AF showed no differences in fibrosis. In functional studies, systolic Ca2+ transient amplitude of LV cardiomyocytes was reduced in patients with AF, while diastolic Ca2+ levels and Ca2+ transient kinetics were not statistically different. These results were confirmed in LV cardiomyocytes from nonfailing donors with sinus rhythm or AF. Moreover, normofrequent AF was simulated in vitro using arrhythmic or rhythmic pacing (both at 60 bpm). After 24 hours of AF-simulation, human LV cardiomyocytes from nonfailing donors showed an impaired Ca2+ transient amplitude. For a standardized investigation of AF-simulation, human iPSC-cardiomyocytes were tested. Seven days of AF-simulation caused reduced systolic Ca2+ transient amplitude and sarcoplasmic reticulum Ca2+ load likely because of an increased diastolic sarcoplasmic reticulum Ca2+ leak. Moreover, cytosolic Na+ concentration was elevated and action potential duration was prolonged after AF-simulation. We detected an increased late Na+ current as a potential trigger for the detrimentally altered Ca2+/Na+-interplay. Mechanistically, reactive oxygen species were higher in the LV of patients with AF. CaMKII (Ca2+/calmodulin-dependent protein kinase IIδc) was found to be more oxidized at Met281/282 in the LV of patients with AF leading to an increased CaMKII activity and consequent increased RyR2 phosphorylation. CaMKII inhibition and ROS scavenging ameliorated impaired systolic Ca2+ handling after AF-simulation.CONCLUSIONS: AF causes distinct functional and molecular remodeling of the human LV. This translational study provides the first mechanistic characterization and the potential negative impact of AF in the absence of tachycardia on the human ventricle.

U2 - 10.1161/CIRCRESAHA.121.319718

DO - 10.1161/CIRCRESAHA.121.319718

M3 - SCORING: Journal article

VL - 130

SP - 994

EP - 1010

JO - CIRC RES

JF - CIRC RES

SN - 0009-7330

IS - 7

ER -